Ignite Creation Date:
2025-12-25 @ 3:05 AM
Ignite Modification Date:
2025-12-26 @ 1:44 AM
Study NCT ID:
NCT00809133
Status:
COMPLETED
Last Update Posted:
2016-03-14
First Post:
2008-12-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2015-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-12-16
First Submit QC Date:
None
Study First Post Date:
2008-12-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-16
Results First Submit QC Date:
None
Results First Post Date:
2016-03-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-02-16
Last Update Post Date:
2016-03-14
Last Update Post Date Type:
ESTIMATED